UTI BSE Sensex Index Fund - Direct Plan - Growth Option

UTI BSE Sensex Index Fund - Direct Plan - Growth Option lags behind most of its peers in the Large Cap category, currently carrying a 1-star rating. Returns have been soft relative to what the category has offered — worth checking if this is a temporary phase or a longer pattern. TopFund's composite Health Score, which weighs rating, 3-year CAGR, expense ratio and fund size, puts it at 46/100.

Cost: At 0.23%, the expense ratio is meaningfully cheaper — about 68% below the Large Cap category average of 0.73% (based on 272 comparable funds). Lower costs compound in your favour over long holding periods.

Risk-adjusted performance: Over the trailing 1-year period, the fund shows a negative Sharpe ratio of -0.88 — over the past year, returns haven't kept pace with the volatility involved, even before accounting for the risk-free rate. Separately, annualised volatility of 13.5% is fairly typical for actively managed equity funds.

Who should invest: This fund is best suited to conservative equity investors or those wanting a stable core holding, typically with a 3+ year horizon. The High risk rating means near-term volatility should be expected — this isn't a fund to check daily.